Seeking Alpha
 

Par Pharmaceutical Companies, Inc. (PRX)

- NYSE
PRX is defunct since October 1, 2012. acquired by a private company
  • Jul. 16, 2012, 8:24 AM
    TPG agrees to acquire Par Pharmaceutical (PRX) for $1.9B, or $50/share, which represents a 37% premium over Par's closing price on Friday. Shares +36% premarket. (PR)
    | Comment!
Visit Seeking Alpha's
Company Description
Par Pharmaceutical Companies, Inc., incorporated in 1978 as Par Pharmaceutical, Inc., is a Delaware holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is in the business of developing, licensing, manufacturing and distributing generic and... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States